Italia markets close in 4 hours 9 minutes

TEVA Jan 2025 7.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,03000,0000 (0,00%)
In data: 03:32PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0300
Aperto0,0300
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio7,00
Scadenza2025-01-17
Min-Max giorno0,0300 - 0,0300
Contratto - Min-MaxN/D
Volume1
Open Interest9,42k
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.